You just read:

Cempra Pharmaceuticals Presents New Data on its Fourth Generation Macrolide, Solithromycin (CEM-101) at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

News provided by

Cempra Pharmaceuticals

Sep 16, 2011, 07:00 ET